About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Myd88em1.1Rsky
endonuclease-mediated mutation 1.1, Klaus Rajewsky
MGI:7281146
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Ighg1tm1(cre)Cgn/Ighg1+
Myd88em1.1Rsky/Myd88+
involves: 129P2/OlaHsd * C57BL/6NTac MGI:7281484
cn2
Cd19tm1(cre/ERT2)Rsky/Cd19+
Myd88em1.1Rsky/Myd88+
involves: 129P2/OlaHsd * C57BL/6NTac MGI:7281485
cn3
Cd19tm1(cre)Cgn/Cd19+
Myd88em1.1Rsky/Myd88em1.1Rsky
involves: C57BL/6NTac MGI:7281480
cn4
Cd19tm1(cre)Cgn/Cd19+
Myd88em1.1Rsky/Myd88+
involves: C57BL/6NTac MGI:7281482


Genotype
MGI:7281484
cn1
Allelic
Composition
Ighg1tm1(cre)Cgn/Ighg1+
Myd88em1.1Rsky/Myd88+
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ighg1tm1(cre)Cgn mutation (3 available); any Ighg1 mutation (28 available)
Myd88em1.1Rsky mutation (0 available); any Myd88 mutation (50 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
N
• normal Ig class switching in germinal center B cells after immunization with hapten-carrier conjugate NP-CGG
• normal rise and fall of hapten-specific IgG levels after immunization with hapten-carrier conjugate NP-CGG
• increased frequency in IgM+ plasma cells
• increased frequency and number
• persistently high number of hapten-specific IgM+ plasma cells in spleen and bone marrow for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• high total plasma cell numbers in spleen and bone marrow for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• increased frequency and number of plasma cells and germinal center B cells
• high total IgM serum levels for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• persistently high hapten-specific IgM levels for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG

immune system
• increased frequency in IgM+ plasma cells
• increased frequency and number
• persistently high number of hapten-specific IgM+ plasma cells in spleen and bone marrow for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• high total plasma cell numbers in spleen and bone marrow for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• increased frequency and number of plasma cells and germinal center B cells
• high total IgM serum levels for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• persistently high hapten-specific IgM levels for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
monoclonal gammopathy of uncertain significance DOID:7442 J:308792




Genotype
MGI:7281485
cn2
Allelic
Composition
Cd19tm1(cre/ERT2)Rsky/Cd19+
Myd88em1.1Rsky/Myd88+
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd19tm1(cre/ERT2)Rsky mutation (1 available); any Cd19 mutation (57 available)
Myd88em1.1Rsky mutation (0 available); any Myd88 mutation (50 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• 15x increase in spleen 10 days after tamoxifen tre
• persistently high number of IgM+ plasma cells in spleen and bone marrow for at least 70 weeks after tamoxifen treatment
• high total IgM serum levels for at least 70 weeks after tamoxifen treatment, displaying discrete paraprotein bands in the gamma-globulin zone upon serum protein electrophoresis

immune system
• 15x increase in spleen 10 days after tamoxifen tre
• persistently high number of IgM+ plasma cells in spleen and bone marrow for at least 70 weeks after tamoxifen treatment
• high total IgM serum levels for at least 70 weeks after tamoxifen treatment, displaying discrete paraprotein bands in the gamma-globulin zone upon serum protein electrophoresis

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
monoclonal gammopathy of uncertain significance DOID:7442 J:308792




Genotype
MGI:7281480
cn3
Allelic
Composition
Cd19tm1(cre)Cgn/Cd19+
Myd88em1.1Rsky/Myd88em1.1Rsky
Genetic
Background
involves: C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd19tm1(cre)Cgn mutation (11 available); any Cd19 mutation (57 available)
Myd88em1.1Rsky mutation (0 available); any Myd88 mutation (50 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• transient expansion of B cells in absence or presence of added mitogens in vitro

hematopoietic system
• transient expansion of B cells in absence or presence of added mitogens in vitro

immune system
• transient expansion of B cells in absence or presence of added mitogens in vitro




Genotype
MGI:7281482
cn4
Allelic
Composition
Cd19tm1(cre)Cgn/Cd19+
Myd88em1.1Rsky/Myd88+
Genetic
Background
involves: C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd19tm1(cre)Cgn mutation (11 available); any Cd19 mutation (57 available)
Myd88em1.1Rsky mutation (0 available); any Myd88 mutation (50 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
N
• normal B cell development in bone marrow
• normal Ig class switching in B cells in spleen, mesenteric lymph nodes and Peyers patches
• from age 30 weeks
• increased frequency and number from age 30 weeks, increasing over time
• increased number of IgM+ plasma cells
• increased plasma cell compartment in spleen and bone marrow
• increased frequency and number of TACI+ CD138+ plasma cells from age 50 weeks
• increased frequency and number of germinal center B cells from age 30 weeks, increasing over time
• normal frequency of follicular and marginal zone B cells
• increased serum levels from age 10 weeks, increasing over time

immune system
• from age 30 weeks
• increased frequency and number from age 30 weeks, increasing over time
• increased number of IgM+ plasma cells
• increased plasma cell compartment in spleen and bone marrow
• increased frequency and number of TACI+ CD138+ plasma cells from age 50 weeks
• increased frequency and number of germinal center B cells from age 30 weeks, increasing over time
• normal frequency of follicular and marginal zone B cells
• increased serum levels from age 10 weeks, increasing over time

growth/size/body
• from age 30 weeks





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
07/05/2024
MGI 6.24
The Jackson Laboratory